Introducing the new Cas9 ELISA Assay from Xpressbio, available in Australia, NZ and the Pacific from Banksia Scientific.
The assay can be used to monitor S. pyogenes Cas9 in cell culture lysate and is ideal for screening experimental samples utilising the CRISPR/Cas9 gene editing system.
Excerpt from the Cas9 ELISA Assay insert:
Microtitration wells coated with murine anti-Cas9 capture antibody are exposed to test specimens, which may contain Cas9 reactive determinants. The Cas9 antigen in the specimen is specifically captured onto the immobilized antibody during specimen incubation. The captured antigen is then reacted with a biotinylated mouse monoclonal Cas9 detection antibody. Subsequently, Streptavidin-HRP conjugate is then added. Following a wash cycle, specifically bound enzyme conjugate is detected by reaction with the Substrate Solution, tetramethylbenzidine (TMB). The assay is measured spectrophotometrically to indicate the level of Cas9 reactive determinants present in a sample. The assay can be used to monitor S. pyogenes Cas9 in cell culture lysate and is ideal for screening experimental samples utilizing the CRISPR/Cas9 gene editing system.
Banksia Scientific provides the full range of Xpressbio products, including:
- Lab animal health monitoring
- Quantitative biomarker assays
- Viral core antigens
- Vaccine research products
- PDEF and more
Cas9 ELISA Assay Sales Enquiries
Call Banksia on 1300 769 944, +617 3902 3000, email or complete the below form.